N
Google TrendSOX SCORE (1000+) — MLB playoffs 2026: Inside White Sox's postseason pitching plan
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Google Trends:sox score1000+bill maher500+ben simmons500+lisa200+sherrod brown1000+mn gophers2000+will venable1000+kalshi1000+
Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Synthetic control arm: th" (30 stories)

Top Headline Story

Could AI Replace Half of Clinical Trials? How Synthetic Control Arms Are Changing Diabetes Drug Development
Lead StoryDiabetes In Controltech
Jul 17

Could AI Replace Half of Clinical Trials? How Synthetic Control Arms Are Changing Diabetes Drug Development

<a href="https://news.google.com/rss/articles/CBMiigFBVV95cUxOVDZmd0x3RDhwNHhKYVZMbGpWUHM5b3pIMi01a0dCR1lZaFVVMUw3clpzNTF0YWFsal9oTl95eWNqQ3BqVmk1dEtlYmVIRkZpQ1djU2VKOVA2MXhMSEdabEg4U0Jta3oxZEsxYWZqOGdicHdvQmFSa1Q2MmF3M1VsSHVEWkdOclZ3N1E?oc=5" target="_blank">Could AI Replace Half of Clinical Trials? How Synthetic Control Arms Are Changing Diabetes Drug Development</a>  <font color="#6f6f6f">Diabetes In Control</font>

Read Full StoryRelated Trends

Google Trends & Trending Search Intelligence

Real-time search volume
1000+23m ago

sox score

MLB playoffs 2026: Inside White Sox's postseason pitching plan

Filter stories
500+23m ago

bill maher

Michael Douglas Tells Bill Maher About Smuggling Marijuana in Suitcases, Slams ‘Nepo Baby’ Label

Filter stories
500+23m ago

ben simmons

Ben Simmons to make his Kings debut against Golden State

Filter stories
200+23m ago

lisa

Trump Announces White House Inquiry Into Fed Governor Lisa Cook

Filter stories

Search Results for "Synthetic control arm: th"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Rethinking Clinical Trials with Synthetic Control Arms
www.the-scientist.comgeneral

Rethinking Clinical Trials with Synthetic Control Arms

<a href="https://news.google.com/rss/articles/CBMilAFBVV95cUxNeC1IR2lhS1FENmpDTURmWXg2dTVqVVFwTzI4ZkNMY1NiXzhZT1p5a3RTMllfZ0VzdDF1VjFic2ZTRGFRRmdCNXZkQnlxZGNDOUFqNngydnlSYld3bmljVlpQQlRkeFVGcXpneTlpOWZ1R0VvUldqZ0p3SHlrQmRnLTk4YUtKS3VXVlVMa0xWaXlySHJx?oc=5" target="_blank">Rethinking Clinical Trials with Synthetic Control Arms</a>  <font color="#6f6f6f">www.the-scientist.com</font>

Read Full StoryMore like this
What Makes the Synthetic Control Design of ARASEC Innovative
Urology Timesgeneral

What Makes the Synthetic Control Design of ARASEC Innovative

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxNcUZRZjBXRFhpTk1nOEs2SE5LQ3MwMjlOOU10dmFwb3B3MWlReUhkV2RyX0tZUDVDU2U5UmdWRHgtQzBEN0kzMF8yakd2c25QRnBuS2ttakRPUzNUaTVodndoSXRjUnNVQi1IeGRPUW50UmFuMnZUcERHNURVUm12b3ZOVWloVlFYT01QYkFFeEhNRHFFQlVtSW9B?oc=5" target="_blank">What Makes the Synthetic Control Design of ARASEC Innovative</a>  <font color="#6f6f6f">Urology Times</font>

Read Full StoryMore like this
Advancing Clinical Trials and Decision-Making With Synthetic Real-World Data
The ASCO Postworld

Advancing Clinical Trials and Decision-Making With Synthetic Real-World Data

<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxQdVRMOGtiaFQ3NDU1a3g2RndQeXJpQVBDUWNleXV0OUxXS0JwZTZkS2FnMGt3R3ppRjVxbFJsTHZ4eGxzOHU1WWFLUzY0a0xSYUdmenNLT3kxTXFpNEJGMmhoQkFjb3Fmd096dU5Nd245U19wcUhUU1FQbHZYTHJfWUxxZWRybmVlVmZOLXJLNzg0UzdheXhfYWlyUkZocThSWXFvd3BZamNTajk3Y0lxMFZRbWEwQ29UMnc?oc=5" target="_blank">Advancing Clinical Trials and Decision-Making With Synthetic Real-World Data</a>  <font color="#6f6f6f">The ASCO Post</font>

Read Full StoryMore like this
Artificial intelligence (AI) is rapidly spreading to the entire clinical trial process beyond the st..
매일경제tech

Artificial intelligence (AI) is rapidly spreading to the entire clinical trial process beyond the st..

<a href="https://news.google.com/rss/articles/CBMiS0FVX3lxTE9IVDFPNnBMT0gyTGtNdTlSREtneXRPczRQLXRqVkZrWnhVZkJiTVdRTFp1cGthZFY3ZUpZeVROaGdVd2lWTXRNbUlIVQ?oc=5" target="_blank">Artificial intelligence (AI) is rapidly spreading to the entire clinical trial process beyond the st..</a>  <font color="#6f6f6f">매일경제</font>

Read Full StoryMore like this
The Pros And Cons Of Synthetic Control Arms In Clinical Trials
Clinical Leadergeneral

The Pros And Cons Of Synthetic Control Arms In Clinical Trials

<a href="https://news.google.com/rss/articles/CBMipAFBVV95cUxNTUVuWkxpSklId2ZWd2U5ZUU5SDFMMV82WXFEWThyUlgtYVFSY2Rqb1dVVU84N21XVTJ6SjZzRUJyX1hMTkdhMDZVVEwxNFBlaWxsak1ORzE1U3paQThSdndpcGxuRTE5WXI3aEpGY21nTGROWUFJdTdyVllIdTJEZ3lvdWRKVkduQVRZajFXb05LVVdjODlwZzZJOUpfZkR6b1BHXw?oc=5" target="_blank">The Pros And Cons Of Synthetic Control Arms In Clinical Trials</a>  <font color="#6f6f6f">Clinical Leader</font>

Read Full StoryMore like this
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal
Natureworld

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1ZSTNVTjJCVFduenpaNWRvYlJJSzJoRnR1WWFOWWwwclVRdjdZY1J4MGI2SnBpbnpsZ3FIVHBNUlp2VTFGYU5peXdVZEhmQkpUWE5GR3BlcjMyRkx5WElR?oc=5" target="_blank">Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials | Blood Cancer Journal</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Will synthetic control arms revolutionize clinical trials?
Serviergeneral

Will synthetic control arms revolutionize clinical trials?

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxPSGxfay1WN1M1a0dNRTREWVBfeGJCWUVJMmU2NjFSaXp4by0taUJQczBQeTAyNnl0VUtrVlYwVVpQTldCWi03blEyWF9IRXBwYVlueE0wUUVGaXlKNUJiYkVqOG90MjNVcWFkTlp2MUtSajdlVllHdW9sd2RMY1B6eVU1enNmVHV3S241aUpR?oc=5" target="_blank">Will synthetic control arms revolutionize clinical trials?</a>  <font color="#6f6f6f">Servier</font>

Read Full StoryMore like this
Synthetic control arms: full impact yet to be realised
Clinical Trials Arenageneral

Synthetic control arms: full impact yet to be realised

<a href="https://news.google.com/rss/articles/CBMiowFBVV95cUxNa3pZQ2pnSHd3VnR6Zmk5SlAtQlJJeHhoZDdqUDJCek44Zm1tYlc1TEZCbmpEdzVmV1k2YWZORnF0dUJDTnhmUnlyZi02cUk2SEZXV2NTenVyVk5FWlJfcW9oQTUzZGJQYXFuVks3dzMwNDRucTh5Tko4UzFIel9RZlRlUTZiNS1WUnVZYXVoMDJvNjdoZmhCVWlFaTg3dzlUNGJZ?oc=5" target="_blank">Synthetic control arms: full impact yet to be realised</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
2025 Trends: Leveraging Real-World Data for Synthetic Control Arms
Applied Clinical Trialsworld

2025 Trends: Leveraging Real-World Data for Synthetic Control Arms

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxOYWVFV2ZMMHdXZXRCcm1xMFpHVmVxRHNxUzNJRlFLUXVabTNyNVlnSHBhVHduejg3RncxUDhNNjU1WEtTTVRGY2M2dmdsbXRNS2x2bEJBZmc2S25pdmRtd0w2OUMzVWlvc1hqV1dyeHNDX2NlUnhyTnQ3TGZTdEVxbF9ocy1ReDIzbkxwWEV4SG5kNWI5Q21jNERHazJ4eTVlUFFOOUc0Qlo3UGRYaXRv?oc=5" target="_blank">2025 Trends: Leveraging Real-World Data for Synthetic Control Arms</a>  <font color="#6f6f6f">Applied Clinical Trials</font>

Read Full StoryMore like this
Synthetic control arm: the end of placebos?
AbbViegeneral

Synthetic control arm: the end of placebos?

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQWVB2UFM0YktSQXdPa0hxMzhDN29aSHpLRmdDY0laNi1YV3hVLWtObmFtN0VwZWhxZVJtM3ZFSjVtQXdWR293ejhrVnBSUDg0SUZtdGJneVBreF9ZZFkzTUsyQW5qeU51MjUyODEycTc2NEMtWUNGWXlEQU1lZmE0VXVHRWw0MmwzMm5IdG5B?oc=5" target="_blank">Synthetic control arm: the end of placebos?</a>  <font color="#6f6f6f">AbbVie</font>

Read Full StoryMore like this
When placebos aren’t an option: synthetic control arms in rare and severe diseases
Drug Discovery Newsgeneral

When placebos aren’t an option: synthetic control arms in rare and severe diseases

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPNnBzLXdfc0VZOVBPUFJJcTBlTXdYOTFIM2NzWk5sTDhRSWxLTjhtQlpCYlVYMFJmRXBnRnVKcUlkVEw3MkN1OXhfeTkxanJhYXJ5bHp6dlpxTWlTSVFfa3JBeDhaUnZtSDZaY0F3S2lNSUgtVWRReWFkVnRwTDNNVktHMW0zTDdxVUx6MGxyR2VVOFh4N0s3V280TXktT2ZNcDRmams3MS1nZFo5aUlCRGwtdnJvSUJzS1BsU0hR?oc=5" target="_blank">When placebos aren’t an option: synthetic control arms in rare and severe diseases</a>  <font color="#6f6f6f">Drug Discovery News</font>

Read Full StoryMore like this
Synthetic Control Arm Replicates Outcomes From Historical Data
Cancer Therapy Advisorgeneral

Synthetic Control Arm Replicates Outcomes From Historical Data

<a href="https://news.google.com/rss/articles/CBMisgFBVV95cUxNbkpOOEJaNXRLdXZZVXNTRnExdnhDR3hEYTJfcHk2dlBjWUlBZEFxMTI3UHhfZElINW5QNVU1cnZwRXUwYVRYSFY3ZWgzak9EQy1rWDNvSXdLQjRoa3h6LXgtZnZaRG1FZTZaZ212NTFKVXN5ZjZrSjNHVlM4WEFNNU03WHRoRG5ET2tNWURYMUUtT2x2amlKWkFuMWNCaTJIZWhhZ1ZDWi1oemJ4d3VnZ0JR?oc=5" target="_blank">Synthetic Control Arm Replicates Outcomes From Historical Data</a>  <font color="#6f6f6f">Cancer Therapy Advisor</font>

Read Full StoryMore like this
Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma
Dassault Systèmesgeneral

Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma

<a href="https://news.google.com/rss/articles/CBMipwJBVV95cUxOcXpDaVpNS04zT1NkYVNIOE5PZkU0TEtLeFhlbTFCU0c0VF9ZWnpEa09pLWpxYmZMZW10VkFfMVhsdGJKakYtSjVIMFJSM3VaZHJrN1BXRElQcmJoUERramhsMU5hVUoxdXlWNlNHTFBjMTZ5RDl0ZnEzeG1oYWxMbnRQSjA3LTJCb2JFWkF2OFZhUDh3SHZIcERqSHVJel92NlRCWS1vNmMwQTlLekxzR2pYU09Sdm1rYUJDNVhDSi1hNEQ0Q1pzY2FhWFRlVXh1ZUpHMDVNWTMwMWVJR3M1enBFYWNSNXFaLXBVSzRSNWVvaVpzOEhwd3dDQUdPYXBSbkRSRmQtYjNadmFXQjVUSW1Id3RnQ1k4ZWo2Xzc2Z1NKS01oeng4?oc=5" target="_blank">Medidata Synthetic Control Arm Supported by the US Food and Drug Administration for Use in Medicenna Therapeutics, Corp. Phase 3 Registrational Trial in Recurrent Glioblastoma</a>  <font color="#6f6f6f">Dassault Systèmes</font>

Read Full StoryMore like this
Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer
Natureworld

Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9BdldQa3JIRmxMcWZkbU9IVU9NVlExemVUWHpzYkJPRDZENzVJd1ZSOUFCZUxfQXNEbkZ5R0lZTDF6SldoRy1WNG5RRFBaYl9VWm8xLU5aQUdmQXRMLVZB?oc=5" target="_blank">Addressing challenges with real-world synthetic control arms to demonstrate the comparative effectiveness of Pralsetinib in non-small cell lung cancer</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Synthetic Control Arms: A Broader Clinical reach
PharmaVoicegeneral

Synthetic Control Arms: A Broader Clinical reach

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxQQWVEUnM0Y2JCMWRKRjZFeGNXeXkwSFFjZXRHd1d1RGc0bGhvT25JbHEzelJjanZJSWxhN2JZeDgteEJiempXQmZlRFZLWG4zakJiWFBtYlV1T0p4T1hmMjY5RFpVd1h6OUNpanN5QzV1bzRJTW45WXdpRHJxVGxJeTNaVHoyang4ODhwSVRPMHVmMThSV3F1dVZ1Rnk?oc=5" target="_blank">Synthetic Control Arms: A Broader Clinical reach</a>  <font color="#6f6f6f">PharmaVoice</font>

Read Full StoryMore like this
Synthetic control arms can save time and money in clinical trials
STATgeneral

Synthetic control arms can save time and money in clinical trials

<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxOUzY1TUstU3M2VER5UGlfdDFIYnRhRzlqMHlLbDVRMFlfcmt3aXh4c0t2UXNyVXJ6V0x0MUVzbGp1eG9paHRtVjRVZTNUenZ4eUpzVDZqMmhXOW9wZ29ReGpZNGEyT25vNF82MGZ4ZVJOUTJIZzRCZDA3eWpYMjNjNA?oc=5" target="_blank">Synthetic control arms can save time and money in clinical trials</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
Utilising real-world data to overcome challenges in rare disease research
Clinical Trials Arenaworld

Utilising real-world data to overcome challenges in rare disease research

<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQRjFmYVp5bUoxM1d6LVBhT2F4UHprYVdYeDNhSDF0bkRLY1RvbzQ1dnE4bVhTZDQySEpGRDdUTllnZHEzaVZva1Z6ZDQxbjlQTXB2TGVfWko1d1B1SEFOZHlHbmtZSTJONHFEbEpWQm85UklJdU13Q3NWYWwzM25tbEtSeTByQlRpSVI5NGR3amlrU0dyQ3hWWHFzWlRldEQtcmdVdHVaLUNpeXRsR2hCcWRpalZKZw?oc=5" target="_blank">Utilising real-world data to overcome challenges in rare disease research</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
ERS 2025: Benefits of synthetic control arms reinforced with buloxibutid’s results
Clinical Trials Arenageneral

ERS 2025: Benefits of synthetic control arms reinforced with buloxibutid’s results

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxPU0lEWnF2Umd0c25jU0FIVTdXUnZ2ZkE2LWpPbWt3eXMwZ21QaFNLWGZCaUdTRkxEUzl4MHk3eE1xSnBjanBwYkc1UjNoN0hxM09rYzJSeGJWWnF5cXg1eFc1RkJJNGI4cVRWN000bHFRSkQ3VFhCazJVNUlrazQxbkc0Mjh0VE1hQnhFVmdqMmNQaGRUREJSOEl1ZEU?oc=5" target="_blank">ERS 2025: Benefits of synthetic control arms reinforced with buloxibutid’s results</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors
Naturegeneral

Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE12SUdEWVcyR2M1TnV1bXI5OXItemx3OTBlRHRJRG40M3FFSm4zV2JKSnB0b21lejFxRnhGbDBGaDhfYndocjdCMXllMjU1M3B4UGVzd0hjNmx6OUZqM3dR?oc=5" target="_blank">Rethinking placebos: embracing synthetic control arms in clinical trials for rare tumors</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
Synthetic control arms in clinical trials: Making it happen
pharmaphorumgeneral

Synthetic control arms in clinical trials: Making it happen

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQckx1M0pKNWdRemFWN1JjaTBnOHhWNlpUS1NDeElJMWtNZUFoYkhCOFd6cVpZdVNDcm9MdHliNjc2UFNUWHFHQXZFOF9lN284RjhOZU1IbTlMUVVaRE9DeUN0U3MzOEUtUUFxRGg1RjBiT1puZlkwSzloMWppZDI4MkdBclg3VGdGbWM4V1Nvcm05eC1kaS1v?oc=5" target="_blank">Synthetic control arms in clinical trials: Making it happen</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
Leveraging AI to generate digital twins and accelerate clinical trials
STATtech

Leveraging AI to generate digital twins and accelerate clinical trials

<a href="https://news.google.com/rss/articles/CBMiwAFBVV95cUxOMlozWWdFM0pBX1hWYkxoZUNJdTJVYm1DRGJvQjZfS3hicUVOQVRCX25tTktCNEJkQnp4aFF5S3E5V1ZaZ1dDTmVPQlViSFlqN193LTlJV09zWVVIODRiYTZDcEcxQ2l5X2YwS2dxLWtURWZUZ2x2Mk01eGtLakthNTBtY1d5RUJNc1pFcHJEQjZtZ3lhTWJfTnFSY2Vua2Zhbmx3U3ltekV0enFDVVhiZ2VIV1J2cUJLSXh2LWlDbWI?oc=5" target="_blank">Leveraging AI to generate digital twins and accelerate clinical trials</a>  <font color="#6f6f6f">STAT</font>

Read Full StoryMore like this
Phase 3 Ritlecitinib Trial Uses Synthetic Controls to Test Higher Dose Efficacy
Dermatology Timesgeneral

Phase 3 Ritlecitinib Trial Uses Synthetic Controls to Test Higher Dose Efficacy

<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOc2l5RHo0TDg0Uk9PQmhhdnNkUGpIY2RjZmxRX2hYVXBTQXF1emxjb25iQ05SUWNOakxRY0tab2pGQ2ZDM25sZjA0aGVhWHJadmE5LUlIemdnQ2NVY3Y3TzJ3ZDFneXVmeVdXdC1teXNnN1c3eTY4MGE5UGRLWU1sXzZJR2dBcEZ2bzMweEQtdlhNVWRISTVvMi1KM1F5b3pEYTZzZWhzcGNBeXlsdFpBRkxoYjRSNnpk?oc=5" target="_blank">Phase 3 Ritlecitinib Trial Uses Synthetic Controls to Test Higher Dose Efficacy</a>  <font color="#6f6f6f">Dermatology Times</font>

Read Full StoryMore like this
Debunking Top 5 Myths about Digital Twins in Clinical Trials
Applied Clinical Trialsworld

Debunking Top 5 Myths about Digital Twins in Clinical Trials

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxOX2cxQnBaY2RBazZpTHV2SnI1WDdJdWlMcXB3QUVYRzBXc3RlMFlKcUdDekg1Nm53X3YyalZuUGoyRDVjSDNwUFJxdzJZNHI4Y3RZeXpESHBKdFF5TDRnOXlULW84UUJENnNlZWhoR3VDLUtRa3c0ZG9XdnlqX1NOUmtRcm1IZ1BsZjNLREM2YndlRW9BMnVQUnpsZWV3R2xEVHlvR1kwMWVrT3kyS1E?oc=5" target="_blank">Debunking Top 5 Myths about Digital Twins in Clinical Trials</a>  <font color="#6f6f6f">Applied Clinical Trials</font>

Read Full StoryMore like this
Rare Disease Day: Revolutionising clinical trial enrolment and retention with technology
Clinical Trials Arenatech

Rare Disease Day: Revolutionising clinical trial enrolment and retention with technology

<a href="https://news.google.com/rss/articles/CBMizAFBVV95cUxPdUxZM1dFUFY4dlJwblJTNVJKYW5SY0tvdWpxQ2pQV3FZSnN4Vkx5RXNiR3hOazk5MnF0MWRTbjJJbmRwZks3VmFMZkg0RGNMalR1clpOY3BhaFdxLVNCay1FcVF2RG5DMUd1aGF2YmF4WXBXd1hBMXNtY3RCdUdjQkNrcFNCM3pIX0Uza2FlTDdscF9mcEt6bk5DaWlSNWFLT3hxTE1LM0JUSTZKWGhDZm9GWWp0NFNMa3puNlQzaTFwVGJGWFlndTQ3d3Q?oc=5" target="_blank">Rare Disease Day: Revolutionising clinical trial enrolment and retention with technology</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
N-Power Medicine Launches Industry’s First Prospective External Control Arm Platform to Dramatically Accelerate Oncology Drug Development and Reduce Reliance on Randomization
Business Wireworld

N-Power Medicine Launches Industry’s First Prospective External Control Arm Platform to Dramatically Accelerate Oncology Drug Development and Reduce Reliance on Randomization

<a href="https://news.google.com/rss/articles/CBMizwJBVV95cUxPQjA2TkJ2RGdXdnF2VmMtd0xvaDQtMEp1Z3dDck5pUk9WVTR2aTQ4Y25xY3BwRDB5YTBZS0ZzUlRsNjhYaURaUzdsaDhrYjhuQUFseTNNRHB0R3dCcXRjVThZdHozQjBjaktuSjk5dzdYR0ZDRzlOdXVETlRXV1FMbmZhc2YxeTI3UHUzV0hPTWFyNm1lcElWN1ZjcU9iRk5haUI1bDVOVVdHamlpU0c1ZFdlSF9iMFlsR2lrVGhQRzRCTjJaT1l2aWVfd0lWcFBiUk00MnowZEs3ZGhXTURsWjV0VlJmVzZwUUF4ckgxWF9BMnlsWjZlVnNudG1uRmFfemZVZlJhdU10RkEwdFVUeGRWRlN4WGdRQmdKM1VKS3ZEbVpZeXpMWE15M25oX2praXZZc200UXdLeF91Q2lCSW4yQURsNnRrVW5mb1RBbw?oc=5" target="_blank">N-Power Medicine Launches Industry’s First Prospective External Control Arm Platform to Dramatically Accelerate Oncology Drug Development and Reduce Reliance on Randomization</a>  <font color="#6f6f6f">Business Wire</font>

Read Full StoryMore like this
Rare Disease Day: Enhancing clinical trial success in rare diseases
pharmaphorumgeneral

Rare Disease Day: Enhancing clinical trial success in rare diseases

<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNQUJ5QnVPM3NMRUNFbUduYmZJLXZ3VlZNYzFod0xXWkljandOUldmemdIZlFiTDNtRXE5N2JyZG1OUWl5QXV2QkFFUks0N3ZNWjJ2dk5BeUZ2ODh4Qlc3Z25FS1JseFRTM0VWWl94c1FCLXRwXzQ5dEJZNFptLUJlQnpkX0F2TElvaTZMVmZNUDd5TmVKdVE?oc=5" target="_blank">Rare Disease Day: Enhancing clinical trial success in rare diseases</a>  <font color="#6f6f6f">pharmaphorum</font>

Read Full StoryMore like this
External control arms: when can historical data substitute for placebos?
Clinical Trials Arenageneral

External control arms: when can historical data substitute for placebos?

<a href="https://news.google.com/rss/articles/CBMidkFVX3lxTFBPYUxJVlNjRHUxVm1NRGhQakF1SXFUY0JlaVotMF9MdGtjUTV3bG0wQkxZTTBpZTZGUHJBS0F0aTJSZ0huaHZYNWdmdXFnQWdEZXRYRENreS1DaVM3cmU4ZklhdUFFTHNSMnRuNFFDeWwtcjNFMWc?oc=5" target="_blank">External control arms: when can historical data substitute for placebos?</a>  <font color="#6f6f6f">Clinical Trials Arena</font>

Read Full StoryMore like this
Arcus & Gilead: Quemliclustat Regimens Show Hope in Pancreatic Cancer
The Clinical Trial Vanguardgeneral

Arcus & Gilead: Quemliclustat Regimens Show Hope in Pancreatic Cancer

<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxNTzZuZnFvWjh5R0U1eVpWQWtaWlV4Q0JUNjkzZGJOc1VoUndRUzJWZkxaLWtSbzlWQXJuSkpLMzlReGVhUER2RlNSbmV5TnNrTXlXOFNjMWxvREdwX1kwSXZLS0dhQzc1cXdnUS1IT0lucG9Tel9sbGtLZk0yalV5Nm9iRWRPeFNTUFpueGpPX2c2d1M3UnFBWmZGekYwSVVqeTI4U2NHOWVJa29TZ1Zj?oc=5" target="_blank">Arcus & Gilead: Quemliclustat Regimens Show Hope in Pancreatic Cancer</a>  <font color="#6f6f6f">The Clinical Trial Vanguard</font>

Read Full StoryMore like this
FedECA: federated external control arms for causal inference with time-to-event data in distributed settings
Naturemarkets

FedECA: federated external control arms for causal inference with time-to-event data in distributed settings

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5fZzZ0c1ZfanFPUzNsWGpFYVBNZWhQNUV5a3ZqOXJSNEF5amFZWWVTNS1jQllrd04xSG1EVmdjMnJQaWl2Q2lvWFdCMWE0RVlqdExhcDQ0blk2X2M3anZF?oc=5" target="_blank">FedECA: federated external control arms for causal inference with time-to-event data in distributed settings</a>  <font color="#6f6f6f">Nature</font>

Read Full StoryMore like this
"Synthetic control arm: th" — Live Google News Trends & Headlines